Proteus vulgaris Response to Various Antibacterial Agents
Abstract
Proteus vulgaris is commonly associated with urinary tract infections, wound infections and sepsis. The ability of microorganisms to resist antibiotic actions is referred to as antibiotic resistance. Objective: To compare the antibacterial effects of various medications on clinical isolates of P. vulgaris was the goal. Methods: Over the course of a year, 1000 samples were collected in a cross-sectional study at a hospital in Lahore, Pakistan. The Kirby-Bauer disc diffusion technique was used to test for antibiotic susceptibility. Results: It was determined that the most efficient antibacterial medicines against P. vulgaris. were Imipenem, Gentamycin, Amikacin, Augmentin, Linezolid, Levofloxacin, Ceftazidime, Norfloxacine, and Cefazolin. On the other hand, Meropenem, Cephalothin, Rifampicin, Cefoxitin, and Ampicillin had little effect on Proteus vulgaris. Conclusions: The study emphasizes the significance of preventative measures, such as responsible antibiotic use, the development of novel treatments, and the application of infection control techniques in healthcare settings, to effectively manage and prevent the spread of resistance. Antibiotic resistance in P. vulgaris is becoming a growing cause for concern.
How strong is the evidence?
Evidence Hub reads this as a cross-sectional. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.